Leadership Overview
Sumitomo Pharma has 4 executives leading key functions including corporate strategy, clinical support services, legal compliance, and medical research.
Driven by a commitment to innovative healthcare, Sumitomo Pharma advances global health through specialized R&D in psychiatry, neurology, and oncology while pioneering regenerative medicine and frontier business solutions to address complex social health challenges.
Driven by a commitment to innovative healthcare, Sumitomo Pharma advances global health through specialized R&D in psychiatry, neurology, and oncology while pioneering regenerative medicine and frontier business solutions to address complex social health challenges.
Leadership Roles at Sumitomo Pharma
Shinichiro Katayanagi - Chair and Chief Executive Officer
Shinichiro Katayanagi, the Chair and Chief Executive Officer at Sumitomo Pharma, directs the overarching corporate strategy and long-term vision for the organization. Katayanagi oversees the integration of cutting-edge technologies into the core R&D pipeline, specifically targeting advancements in psychiatry, neurology, and oncology. By aligning internal research capabilities with global market demands, the Chair and Chief Executive Officer ensures the company maintains a competitive edge in the pharmaceutical sector. This leadership role involves constant collaboration with the Board to refine the mission of delivering innovative medical solutions. Shinichiro Katayanagi drives the expansion of frontier business initiatives, focusing on healthcare solutions that extend beyond traditional pharmaceuticals. Through rigorous oversight of operational efficiency and strategic resource allocation, the executive secures the financial health of the firm. Ultimately, Katayanagi fosters a culture of scientific excellence that supports the development of life-changing therapies for patients worldwide.
Jennifer Henderson - Senior Director, CSS & Toq Chief of Staff
Jennifer Henderson, the Senior Director, CSS & Toq Chief of Staff at Sumitomo Pharma, manages the operational workflows within the Clinical Support Services division. Henderson coordinates cross-functional teams to streamline the execution of complex clinical trials, ensuring adherence to global regulatory standards. By optimizing internal processes, the Senior Director, CSS & Toq Chief of Staff facilitates the rapid transition of research findings into viable healthcare products. This role requires constant interaction with executive leadership to align departmental goals with the broader corporate mission of addressing unmet medical needs. Jennifer Henderson drives the implementation of new administrative frameworks that enhance productivity across the organization. Through meticulous planning and resource management, the executive supports the successful delivery of oncology and neurology projects. Ultimately, Henderson maintains the operational integrity required to sustain the company's commitment to high-quality pharmaceutical development and innovative patient care solutions.
Tara Soni - Chief Legal Officer
Tara Soni, the Chief Legal Officer at Sumitomo Pharma, directs all legal affairs, intellectual property protection, and corporate governance initiatives. Soni oversees the complex regulatory landscape governing pharmaceutical R&D, ensuring full compliance across international markets. By mitigating legal risks associated with clinical trials and product commercialization, the Chief Legal Officer protects the company's extensive portfolio of psychiatric and neurological assets. This leadership role involves providing critical counsel to the Board regarding mergers, acquisitions, and strategic partnerships that expand the firm's global footprint. Tara Soni drives the development of robust internal policies that uphold ethical standards in regenerative medicine and cell therapy research. Through proactive management of litigation and contractual obligations, the executive secures the long-term stability of the business. Ultimately, Soni provides the legal framework necessary for the company to pursue its mission of delivering innovative healthcare solutions to patients around the globe.
Armin Szegedi - Chief Medical Officer
Armin Szegedi, the Chief Medical Officer at Sumitomo Pharma, directs the clinical development strategy and medical affairs for the entire product pipeline. Szegedi oversees the scientific rigor of R&D activities, focusing on the efficacy and safety of treatments in psychiatry, neurology, and oncology. By leading clinical trial design and execution, the Chief Medical Officer ensures that new therapies meet the highest standards of medical excellence. This role involves close collaboration with regulatory bodies to facilitate the approval of innovative drugs and regenerative medicine solutions. Armin Szegedi drives the integration of medical insights into the company's frontier business strategy, identifying new opportunities to address complex health issues. Through the management of global medical teams, the executive ensures that clinical data supports the company's market position. Ultimately, Szegedi champions the patient-centric approach that defines the organization's commitment to advancing global health through scientific innovation.
Explore Leadership Teams in Manufacturing
AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines. Its portfolio spans oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, infectious diseases and rare diseases. The company invests heavily in research and development to develop innovative medicines and improve patient outcomes, with operations and a broad commercial presence worldwide.
Company Leadership GB
JZ
AT
Bharat Serums And Vaccines Limited (BSV) is one of India's fastest-growing biopharmaceutical companies, dedicated to developing a wide range of biological, biotech, and pharmaceutical products for over 50 years. The company focuses on critical therapeutic areas such as women's health, critical care, and assisted reproductive technology, aiming to improve health and save lives through innovative treatments. BSV is committed to enhancing the quality of life for patients globally, with a strong emphasis on research and development, supported by a team of over 60 scientists. As a part of the Mankind Group, BSV strives to widen accessibility to its products and deliver positive health outcomes.
Company Leadership SP
RA
AD
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
FC
KW
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership GO
MÇ
CK
Frequently Asked Questions Regarding Sumitomo Pharma Top Executives and Leadership Team
